UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohort

Annals of the rheumatic diseases, 2020-02, Vol.79 (2), p.209

2020

Volltextzugriff (PDF)

Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort

Arthritis research & therapy, 2019-06, Vol.21 (1), p.139-7, Article 139

2019

Volltextzugriff (PDF)

Clinical and molecular insights into cardiovascular disease in psoriatic patients and the potential protective role of apremilast

Frontiers in immunology, 2024-08, Vol.15, p.1459185

2024

Volltextzugriff (PDF)

Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data

Arthritis research & therapy, 2023-06, Vol.25 (1), p.99-99, Article 99

2023

Volltextzugriff (PDF)

Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

Arthritis research & therapy, 2024-02, Vol.26 (1), p.57-57, Article 57

2024

Volltextzugriff (PDF)

Achilles enthesitis on physical examination leads to worse outcomes after 2 years of follow up in patients with ankylosing spondylitis from REGISPONSER-AS registry

Arthritis research & therapy, 2023-01, Vol.25 (1), p.8-8, Article 8

2023

Volltextzugriff (PDF)

Comorbidity management in spondyloarthritis

Rheumatic & musculoskeletal diseases open, 2020-09, Vol.6 (2), p.e001135

2020

Volltextzugriff (PDF)

Clinical profile and treatment utilisation based on HLA-B27 status in axial spondyloarthritis: results from ASAS-PerSpA study

Rheumatic & musculoskeletal diseases open, 2023-07, Vol.9 (3), p.e003179

2023

Volltextzugriff (PDF)

Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry

Rheumatic & musculoskeletal diseases open, 2022-12, Vol.8 (2), p.e002513

2022

Volltextzugriff (PDF)

Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort

Rheumatic & musculoskeletal diseases open, 2024-07, Vol.10 (3), p.e004400

2024

Volltextzugriff (PDF)

Editorial: Clinical manifestations and comorbidities in axial and peripheral spondyloarthritis

Frontiers in medicine, 2022-08, Vol.9, p.980732-980732

2022

Volltextzugriff (PDF)

Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries

Rheumatic & musculoskeletal diseases open, 2023-09, Vol.9 (3), p.e003235

2023

Volltextzugriff (PDF)

Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation

Frontiers in endocrinology (Lausanne), 2024-02, Vol.15, p.1227196-1227196

2024

Volltextzugriff (PDF)

Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study

Rheumatic & musculoskeletal diseases open, 2024-01, Vol.10 (1), p.e003776

2024

Volltextzugriff (PDF)

Uveitis in peripheral spondyloarthritis patients: an ancillary analysis of the ASAS-PerSpA study

Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720-1759720X221119246

2022

Volltextzugriff (PDF)

Different Therapeutic Response to Anti-TNF Drugs in Patients with Axial Spondyloarthritis Depending on Their Clinical Profile: An Unsupervised Cluster Analysis

Journal of clinical medicine, 2024-04, Vol.13 (7), p.1855

2024

Volltextzugriff (PDF)

Distribution of comorbidities in spondyloarthritis with regard to the phenotype and psoriasis: data from the ASAS-COMOSPA study

Therapeutic advances in musculoskeletal disease, 2021, Vol.13, p.1759720X211045263-1759720X211045263

2021

Volltextzugriff (PDF)

Relationship between onset of psoriasis and spondyloarthritis symptoms with clinical phenotype and diagnosis: data from REGISPONSER registry

Therapeutic advances in musculoskeletal disease, 2022-08, Vol.14, p.1759720-1759720X221118055

2022

Volltextzugriff (PDF)

Future Challenges and Critical Approach to Metrology in Patients with Axial Spondyloarthritis

Diagnostics (Basel), 2021-08, Vol.11 (9), p.1533

2021

Volltextzugriff (PDF)

Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients

Rheumatic & musculoskeletal diseases open, 2024-06, Vol.10 (2), p.e004187

2024

Volltextzugriff (PDF)

Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study

Rheumatic & musculoskeletal diseases open, 2024-02, Vol.10 (1), p.e003975

2024

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(106)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohort

Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort

Clinical and molecular insights into cardiovascular disease in psoriatic patients and the potential protective role of apremilast

Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data

Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast

Achilles enthesitis on physical examination leads to worse outcomes after 2 years of follow up in patients with ankylosing spondylitis from REGISPONSER-AS registry

Comorbidity management in spondyloarthritis

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study

Clinical profile and treatment utilisation based on HLA-B27 status in axial spondyloarthritis: results from ASAS-PerSpA study

Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry

Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling

Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort

Editorial: Clinical manifestations and comorbidities in axial and peripheral spondyloarthritis

Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries

Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation

Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study

Uveitis in peripheral spondyloarthritis patients: an ancillary analysis of the ASAS-PerSpA study

Different Therapeutic Response to Anti-TNF Drugs in Patients with Axial Spondyloarthritis Depending on Their Clinical Profile: An Unsupervised Cluster Analysis

Distribution of comorbidities in spondyloarthritis with regard to the phenotype and psoriasis: data from the ASAS-COMOSPA study

Relationship between onset of psoriasis and spondyloarthritis symptoms with clinical phenotype and diagnosis: data from REGISPONSER registry

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Future Challenges and Critical Approach to Metrology in Patients with Axial Spondyloarthritis

Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients

Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study

Suchergebnisse filtern